Concert Pharmaceuticals Inc. said Meghan FitzGerald resigned from the board, effective Dec. 11, due to other work commitments.

FitzGerald works in private equity and resigned her seat because one of her new portfolio companies invests in the biotechnology industry.

Lexington, Mass.-based Concert Pharmaceuticals operates as a clinical-stage biopharmaceutical company.